HPS Pharmacies wish to give notice that Pfizer Australia is experiencing a supply interruption for isoprenaline ampoules as follows:
Isuprel™ 1:5000 Ampoules
Isoprenaline Hydrochloride 200mcg/1mL
Normal supplies of Isuprel™ 1:5000 200mcg/1mL ampoules are currently expected to resume by the 3rd February 2020. Isuprel™ 1:5000 1mg/5mL ampoules have been discontinued.
An internationally registered brand of isoprenaline 200mcg/1mL ampoules has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that Section 19A alternatives are subject to a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 629 921.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates